SABSW
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
SAB Biotherapeutics, Inc.
CEO
Samuel J. Reich
IPO Date
2021-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $0.00 |
| 16 Mar 2023 | Kropotova Alexandra | Chief Medical Officer | A-Award | Acquired | 275,000 | $0.00 |
| 2 Mar 2023 | Spragens Jeffrey G | director | J-Other | Acquired | 19,936 | $11.50 |
| 10 Feb 2023 | HAMILTON CHRISTINE E | director, 10 percent owner: | Disposed | 0 | $0.00 |
| 10 Feb 2023 | HAMILTON CHRISTINE E | director, 10 percent owner: | Disposed | 0 | $0.00 |
| 9 Dec 2022 | HAMILTON CHRISTINE E | director | A-Award | Acquired | 82,987 | $1.21 |
| 9 Dec 2022 | HAMILTON CHRISTINE E | director | A-Award | Acquired | 82,987 | $0.00 |
| 9 Dec 2022 | Spragens Jeffrey G | director | A-Award | Acquired | 82,987 | $1.21 |
| 9 Dec 2022 | Spragens Jeffrey G | director | A-Award | Acquired | 82,987 | $0.00 |